Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily (QD), taken with ezetimibe on cholesterol levels in subjects with primary dyslipidemia
Epistemonikos ID: 5cde8049850c570b895744810afe1897cdfd729d
First added on: May 04, 2024